Gene · 26801
Papers1,424
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,424
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Midsize noncoding RNAs in cancers: a new division that clarifies the world of noncoding RNA or an unnecessary chaos? | Rep Pract Oncol Radiother | 2022 | 36632289 | PubTator, text mining | PubMed |
| miRNA expression profiles of the perilesional skin of atopic dermatitis and psoriasis patients are highly similar. | Sci Rep | 2022 | 36587063 | PubTator, text mining | PubMed |
| Expression profiles of small non-coding RNAs in breast cancer tumors characterize clinicopathological features and show prognostic and predictive potential. | Sci Rep | 2022 | 36585466 | PubTator, text mining | PubMed |
| Overexpression of microRNA-211 in Functional Dyspepsia via Downregulation of the Glial Cell Line-Derived Neurotrophic Factor (GDNF) by Increasing Phosphorylation of p38 MAPK Pathway. | Can J Gastroenterol Hepatol | 2022 | 36569394 | PubTator, text mining | PubMed |
| Cancer-Specific miRNAs Extracted from Tissue-Exudative Extracellular Vesicles in Ovarian Clear Cell Carcinoma. | Int J Mol Sci | 2022 | 36555361 | PubTator, text mining | PubMed |
| Characterization of pulmonary vascular remodeling and MicroRNA-126-targets in COPD-pulmonary hypertension. | Respir Res | 2022 | 36522710 | PubTator, text mining | PubMed |
| MicroRNA29B induces fetal hemoglobin via inhibition of the HBG repressor protein MYB in vitro and in humanized sickle cell mice. | Front Med (Lausanne) | 2022 | 36507536 | PubTator, text mining | PubMed |
| A Panel of Circulating microRNAs as a Potential Biomarker for the Early Detection of Gastric Cancer. | Avicenna J Med Biotechnol | 2022 | 36504565 | PubTator, text mining | PubMed |
| The Evidence That 25(OH)D3 and VK2 MK-7 Vitamins Influence the Proliferative Potential and Gene Expression Profiles of Multiple Myeloma Cells and the Development of Resistance to Bortezomib. | Nutrients | 2022 | 36501221 | PubTator, text mining | PubMed |
| MiR-199a-3p Induces Mesenchymal to Epithelial Transition of Keratinocytes by Targeting RAP2B. | Int J Mol Sci | 2022 | 36499729 | PubTator, text mining | PubMed |
| The clinicopathological and microrna expression signature associated with lymphovascular invasion in squamous cell carcinoma: A basic descriptive study. | Health Sci Rep | 2022 | 36447566 | PubTator, text mining | PubMed |
| Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma. | Theranostics | 2022 | 36438490 | PubTator, text mining | PubMed |
| MiR-223 Exclusively Impairs In Vitro Tumor Growth through IGF1R Modulation in Rhabdomyosarcoma of Adolescents and Young Adults. | Int J Mol Sci | 2022 | 36430468 | PubTator, text mining | PubMed |
| The Potential of MicroRNAs as Clinical Biomarkers to Aid Ovarian Cancer Diagnosis and Treatment. | Genes (Basel) | 2022 | 36360295 | PubTator, text mining | PubMed |
| Urinary miRNAs as a Diagnostic Tool for Bladder Cancer: A Systematic Review. | Biomedicines | 2022 | 36359288 | PubTator, text mining | PubMed |
| EGFR-induced suppression of HPV E6/E7 is mediated by microRNA-9-5p silencing of BRD4 protein in HPV-positive head and neck squamous cell carcinoma. | Cell Death Dis | 2022 | 36333293 | PubTator, text mining | PubMed |
| Investigation of miRNA and cytokine expressions in latent tuberculosis infection and active tuberculosis. | Turk J Med Sci | 2022 | 36326316 | PubTator, text mining | PubMed |
| Epigenetic regulation of MIR145 core promoter controls miR-143/145 cluster in bladder cancer progression and treatment outcome. | Mol Ther Nucleic Acids | 2022 | 36320325 | PubTator, text mining | PubMed |
| Study of KRAS-Related miRNA Expression in Colorectal Cancer. | Cancer Manag Res | 2022 | 36262749 | PubTator, text mining | PubMed |
| mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma. | Front Oncol | 2022 | 36203462 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26801/papers?page=6